Young Ho Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Young Ho Kim has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Sang Hak Lee
Department of Chemistry Kyungpook National University Daegu 702‐701 South Korea
7 shared publications - Al-Mahmnur Alam
Department of BIN Fusion Technology, Chonbuk National University, Jeonju 561-756, South Korea
6 shared publications Mohammad Kamruzzaman
Department of Chemistry Kyungpook National University Daegu 702‐701 South Korea
6 shared publicationsSung Hong Kim
Korea Basic Science Institute Daegu Center
3 shared publicationsGyu Man Kim
Kyungpook National University
2 shared publicationsGyu-Man Kim
Kyungpook National University
2 shared publications
Latest Publications
- 30 May 2013
- Published by Wiley in Luminescence
- Vol. 29 (3) , 248-253
Chemiluminescence determination of moxifloxacin in pharmaceutical and biological samples based on its enhancing effect of the luminol–ferricyanide system using a microfluidic chip
A sensitive determination of a synthetic fluoroquinolone antibacterial agent, moxifloxacin (MOX), by an enhanced chemiluminescence (CL) method using a microfluidic chip is described. The microfluidic chip was fabricated by a soft‐lithographic procedure using polydimethyl siloxane (PDMS). The fabricated PDMS microfluidic chip had three‐inlet microchannels for introducing the sample, chemiluminescent reagent and oxidant, and a 500 µm wide, 250 µm deep and 82 mm long microchannel. An enhanced CL system, luminol–ferricyanide, was adopted to analyze the MOX concentration in a sample solution. CL light was emitted continuously after mixing luminol and ferricyanide in the presence of MOX on the PDMS microfluidic chip. The amount of MOX in the luminol–ferricyanide system influenced the intensity of the CL light. The linear range of MOX concentration was 0.14–55.0 ng/mL with a correlation coefficient of 0.9992. The limit of detection (LOD) and limit of quantification (LOQ) were 0.06 and 0.2 ng/mL respectively. The presented method afforded good reproducibility, with a relative standard deviation (RSD) of 1.05% for 10 ng/mL of MOX, and has been successfully applied for the determination of MOX in pharmaceutical and biological samples. Copyright © 2013 John Wiley & Sons, Ltd.
- 30 May 2013
- Published by Wiley in Luminescence
- Vol. 29 (3) , 248-253
Chemiluminescence determination of moxifloxacin in pharmaceutical and biological samples based on its enhancing effect of the luminol–ferricyanide system using a microfluidic chip
A sensitive determination of a synthetic fluoroquinolone antibacterial agent, moxifloxacin (MOX), by an enhanced chemiluminescence (CL) method using a microfluidic chip is described. The microfluidic chip was fabricated by a soft‐lithographic procedure using polydimethyl siloxane (PDMS). The fabricated PDMS microfluidic chip had three‐inlet microchannels for introducing the sample, chemiluminescent reagent and oxidant, and a 500 µm wide, 250 µm deep and 82 mm long microchannel. An enhanced CL system, luminol–ferricyanide, was adopted to analyze the MOX concentration in a sample solution. CL light was emitted continuously after mixing luminol and ferricyanide in the presence of MOX on the PDMS microfluidic chip. The amount of MOX in the luminol–ferricyanide system influenced the intensity of the CL light. The linear range of MOX concentration was 0.14–55.0 ng/mL with a correlation coefficient of 0.9992. The limit of detection (LOD) and limit of quantification (LOQ) were 0.06 and 0.2 ng/mL respectively. The presented method afforded good reproducibility, with a relative standard deviation (RSD) of 1.05% for 10 ng/mL of MOX, and has been successfully applied for the determination of MOX in pharmaceutical and biological samples. Copyright © 2013 John Wiley & Sons, Ltd.
- 6 December 2012
- Published by Wiley in Luminescence
- Vol. 28 (6) , 915-921
Determination of sulpiride in pharmaceutical preparations and biological fluids using a Cr (III) enhanced chemiluminescence method
A highly sensitive and simple method for identifying sulpiride in pharmaceutical formulations and biological fluids is presented. The method is based on increased chemiluminescence (CL) intensity of a luminol–H2O2 system in response to the addition of Cr (III) under alkaline conditions. The CL intensity of the luminol–H2O2–Cr (III) system was greatly enhanced by the addition of sulpiride and the CL intensity was proportional to the concentration of sulpiride in a sample solution. Various parameters affecting the CL intensity were systematically investigated and optimized for determination of the sulpiride in a sample. Under the optimum conditions, the CL intensity was proportional to the concentration of sulpiride in the range of 0.068–4.0 µg/mL, with a good correlation coefficient of 0.997. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 8.50 × 10‐6 µg/mL and 2.83 × 10‐5 µg/mL, respectively. The method presented here produced good reproducibility with a relative standard deviation (RSD) of 2.70% (n = 7). The effects of common excipients and metal ions were studied for their interference effect. The method was validated statistically through recovery studies and successfully applied for the determination of sulpiride in pure form, pharmaceutical preparations and spiked human plasma samples. The percentage recoveries were found to range from 99.10 to 100.05% for pure form, 98.12 to 100.18% for pharmaceutical preparations and 97.9 to 101.4% for spiked human plasma. Copyright © 2012 John Wiley & Sons, Ltd.
- 6 December 2012
- Published by Wiley in Luminescence
- Vol. 28 (6) , 915-921
Determination of sulpiride in pharmaceutical preparations and biological fluids using a Cr (III) enhanced chemiluminescence method
A highly sensitive and simple method for identifying sulpiride in pharmaceutical formulations and biological fluids is presented. The method is based on increased chemiluminescence (CL) intensity of a luminol–H2O2 system in response to the addition of Cr (III) under alkaline conditions. The CL intensity of the luminol–H2O2–Cr (III) system was greatly enhanced by the addition of sulpiride and the CL intensity was proportional to the concentration of sulpiride in a sample solution. Various parameters affecting the CL intensity were systematically investigated and optimized for determination of the sulpiride in a sample. Under the optimum conditions, the CL intensity was proportional to the concentration of sulpiride in the range of 0.068–4.0 µg/mL, with a good correlation coefficient of 0.997. The limit of detection (LOD) and limit of quantification (LOQ) were found to be 8.50 × 10‐6 µg/mL and 2.83 × 10‐5 µg/mL, respectively. The method presented here produced good reproducibility with a relative standard deviation (RSD) of 2.70% (n = 7). The effects of common excipients and metal ions were studied for their interference effect. The method was validated statistically through recovery studies and successfully applied for the determination of sulpiride in pure form, pharmaceutical preparations and spiked human plasma samples. The percentage recoveries were found to range from 99.10 to 100.05% for pure form, 98.12 to 100.18% for pharmaceutical preparations and 97.9 to 101.4% for spiked human plasma. Copyright © 2012 John Wiley & Sons, Ltd.
- 2 October 2012
- Published by Springer Nature in Biomedical Microdevices
- Vol. 15 (1) , 195-202
Chemiluminescence microfluidic system of gold nanoparticles enhanced luminol-silver nitrate for the determination of vitamin B12
A rapid and sensitive chemiluminescence (CL) system coupled with a microfluidic chip has been presented to determine vitamin B12 (VB12) based on the reaction of luminol and silver nitrate (AgNO3) in the presence of gold nanoparticles (AuNPs). A microfluidic chip was fabricated by a soft-lithographic procedure using polydimethyl siloxane (PDMS) having four inlets and one outlet with a 200 μm wide, 250 μm deep, and 100 mm long microchannel. Ag+ was used as a chemiluminogenic oxidant in this CL reaction which oxidized luminol to produce strong CL signal in the presence of AuNPs. Luminol reacted with AgNO3 under the catalysis of AuNPs to produce luminol radicals which reacted with dissolved oxygen and emitted CL light. The proposed CL system was applied to determine the amount of VB12 in VB12 tablets and multivitamin. Under the optimum conditions, the CL intensity of the system was increased with the concentration of VB12 in the range of 0.25–100 ng mL−1 with the correlation coefficient of 0.9982. The limit of detection was found to be 0.04 ng mL−1 with the relative standard deviation of 1.56 % for five replicate determinations of 25 ng mL−1 of VB12. The CL reaction mechanism was demonstrated by UV-visible spectra and CL emission spectra.
- 2 October 2012
- Published by Springer Nature in Biomedical Microdevices
- Vol. 15 (1) , 195-202
Chemiluminescence microfluidic system of gold nanoparticles enhanced luminol-silver nitrate for the determination of vitamin B12
A rapid and sensitive chemiluminescence (CL) system coupled with a microfluidic chip has been presented to determine vitamin B12 (VB12) based on the reaction of luminol and silver nitrate (AgNO3) in the presence of gold nanoparticles (AuNPs). A microfluidic chip was fabricated by a soft-lithographic procedure using polydimethyl siloxane (PDMS) having four inlets and one outlet with a 200 μm wide, 250 μm deep, and 100 mm long microchannel. Ag+ was used as a chemiluminogenic oxidant in this CL reaction which oxidized luminol to produce strong CL signal in the presence of AuNPs. Luminol reacted with AgNO3 under the catalysis of AuNPs to produce luminol radicals which reacted with dissolved oxygen and emitted CL light. The proposed CL system was applied to determine the amount of VB12 in VB12 tablets and multivitamin. Under the optimum conditions, the CL intensity of the system was increased with the concentration of VB12 in the range of 0.25–100 ng mL−1 with the correlation coefficient of 0.9982. The limit of detection was found to be 0.04 ng mL−1 with the relative standard deviation of 1.56 % for five replicate determinations of 25 ng mL−1 of VB12. The CL reaction mechanism was demonstrated by UV-visible spectra and CL emission spectra.
- 13 June 2012
- Published by Elsevier in Journal of Luminescence
- Vol. 132 (11) , 3053-3057
Spectrofluorimetric quantification of bilirubin using yttrium–norfloxacin complex as a fluorescence probe in serum samples
- 13 June 2012
- Published by Elsevier in Journal of Luminescence
- Vol. 132 (11) , 3053-3057
Spectrofluorimetric quantification of bilirubin using yttrium–norfloxacin complex as a fluorescence probe in serum samples
- 4 January 2012
- Published by Springer Nature in Journal of Fluorescence
- Vol. 22 (3) , 883-890
Silver Nanoparticle-Enhanced Chemiluminescence Method for Determining Naproxen Based on Europium(III)-Sensitized Ce(IV)-Na2S2O4 Reaction
A simple and sensitive chemiluminescence (CL) method coupled with flow-injection technique is proposed to determine naproxen (NAP). The method is based upon the enhancement of the weak CL signal arising from the reaction of Ce(IV) and Na2S2O4 with Eu3+ to form the Eu3+-Ce(IV)-Na2S2O4 system. The CL intensity was significantly increased by the introduction of NAP into this system in the presence of silver nanoparticles (Ag NPs). Examination of the recorded UV–vis spectra and fluorescence spectra indicated that the energy of the intermediate SO2*, which originated from the redox reaction of Ce(IV) and Na2S2O4, was transferred to Eu3+ via NAP and that the process was accelerated by Ag NPs due to their catalytic activity. Under the optimum conditions, the CL intensity was increased with increasing NAP concentration and the correlation was linear (r = 0.9992) over the NAP concentration range of 1–420 ng mL−1. The limit of detection (LOD) was 0.11 ng mL−1 with a relative standard deviation (RSD) of 1.15% for 5 replicate determinations of 200 ng mL−1 NAP. The method was successfully applied to determine NAP in pharmaceutical and biological samples.
- 4 January 2012
- Published by Springer Nature in Journal of Fluorescence
- Vol. 22 (3) , 883-890
Silver Nanoparticle-Enhanced Chemiluminescence Method for Determining Naproxen Based on Europium(III)-Sensitized Ce(IV)-Na2S2O4 Reaction
A simple and sensitive chemiluminescence (CL) method coupled with flow-injection technique is proposed to determine naproxen (NAP). The method is based upon the enhancement of the weak CL signal arising from the reaction of Ce(IV) and Na2S2O4 with Eu3+ to form the Eu3+-Ce(IV)-Na2S2O4 system. The CL intensity was significantly increased by the introduction of NAP into this system in the presence of silver nanoparticles (Ag NPs). Examination of the recorded UV–vis spectra and fluorescence spectra indicated that the energy of the intermediate SO2*, which originated from the redox reaction of Ce(IV) and Na2S2O4, was transferred to Eu3+ via NAP and that the process was accelerated by Ag NPs due to their catalytic activity. Under the optimum conditions, the CL intensity was increased with increasing NAP concentration and the correlation was linear (r = 0.9992) over the NAP concentration range of 1–420 ng mL−1. The limit of detection (LOD) was 0.11 ng mL−1 with a relative standard deviation (RSD) of 1.15% for 5 replicate determinations of 200 ng mL−1 NAP. The method was successfully applied to determine NAP in pharmaceutical and biological samples.
- 8 October 2011
- Published by Springer Nature in Microchimica Acta
- Vol. 176 (1-2) , 153-161
Determination of catecholamines based on the measurement of the metal nanoparticle-enhanced fluorescence of their terbium complexes
- 8 October 2011
- Published by Springer Nature in Microchimica Acta
- Vol. 176 (1-2) , 153-161
Determination of catecholamines based on the measurement of the metal nanoparticle-enhanced fluorescence of their terbium complexes
- 7 June 2011
- Published by Springer Nature in Microchimica Acta
- Vol. 174 (3-4) , 353-360
Method for determination of fluoroquinolones based on the plasmonic interaction between their fluorescent terbium complexes and silver nanoparticles
- 7 June 2011
- Published by Springer Nature in Microchimica Acta
- Vol. 174 (3-4) , 353-360
Method for determination of fluoroquinolones based on the plasmonic interaction between their fluorescent terbium complexes and silver nanoparticles